Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07228286 · ClinicalTrials.gov registry record · Early Phase 1
REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study
A Early Phase 1 study of Disorders of Consciousness, sponsored by Samuel Snider, MD.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT07228286 is a Early Phase 1 study of Disorders of Consciousness that is actively recruiting participants, run by Samuel Snider, MD. The registered enrollment target is 2 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07228286, a Early Phase 1 study of Disorders of Consciousness, is actively recruiting participants, sponsored by Samuel Snider, MD.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
The RE-CONNECT study is an early feasibility study to establish the safety, feasibility, and efficacy of two central thalamic deep brain stimulation targets in patients with chronic disorders of consciousness.
Conditions Studied
Interventions
- DEVICE Deep brain stimulation (DBS) electrode implantation
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2025-11-10 |
| Est. Completion | 2029-02-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07228286
The ClinicalTrials.gov registry entry for NCT07228286 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Samuel Snider, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Disorders of Consciousness appearing as the primary indexed condition, and to 1 intervention - of which Deep brain stimulation (DBS) electrode implantation is the first listed.
NCT07228286 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07228286 about?
NCT07228286 is a clinical study titled "REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study". The RE-CONNECT study is an early feasibility study to establish the safety, feasibility, and efficacy of two central thalamic deep brain stimulation targets in patients with chronic disorders of consciousness.
What is the current status of trial NCT07228286?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2025-11-10. Estimated completion is 2029-02-10.
What conditions does trial NCT07228286 study?
This clinical trial studies the following conditions: Disorders of Consciousness.
What interventions are being tested in trial NCT07228286?
The interventions under investigation include: Deep brain stimulation (DBS) electrode implantation (DEVICE).
Who is sponsoring clinical trial NCT07228286?
This trial is sponsored by Samuel Snider, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07228286 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.